Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine
Condition: Rotavirus Vaccine Interventions: Biological: RV3-BB; Biological: Trivalent P2-VP8; Biological: Rotarix; Biological: RV3-BB birth dose; Biological: Trivalent P2-VP8 Booster dose Sponsors: PATH; SK Bioscience Co., Ltd.; Murdoch Childrens Research Institute; Children's Hospital Medical Center, Cincinnati; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials
Immunogenicity and Safety of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
Condition: Rotavirus Gastroenteritis Interventions: Biological: Rotavirus RV3 Vaccine (Bio Farma); Other: Placebo Sponsor: PT Bio Farma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials